— Endo International plc (NASDAQ: ENDP) reported Q3 2019 earnings of $0.60 per share, vs. $0.53 expected.
— Revenues fell 2% to $729 million, vs. $709 million expected.
— Specialty Products revenues increased 18% to $132 million.
— Sterile Injectables revenues grew 11% to $264 million.
— FY19 revenues are expected to be between $2.86 billion and $2.89 billion.
— FY19 adjusted EPS from continuing operations is expected to be $2.10 and $2.25.
— ENDP shares were down 3% in premarket hours on Tuesday.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Important takeaways from Paychex’s (PAYX) Q2 2025 earnings report
Paychex Inc. (NASDAQ: PAYX), a leading provider of human resources and payroll services, reported better-than-expected revenue and profit for the second quarter of fiscal 2025, sending the stock higher soon
Lamb Weston’s (LW) challenges may not end soon, a few points to note
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) turned red in mid-day trade on Friday. The stock has dropped 19% in the past one month. The company delivered disappointing results
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
